Bayer's Flanax Claim 'Distorts' Lanham Act, 4th Circ. Told

By Bill Donahue (July 15, 2015, 4:22 PM EDT) -- The small drugmaker at the center of Bayer AG's closely watched trademark case over the foreign brand name for Aleve accused the pharmaceutical giant on Tuesday of trying to "distort the Lanham Act" by claiming rights in a name it's never used domestically....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!